Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
Published: 2019-05-02

Get a Quote or Let Us Help You!

If you'd like to explore your insurance options, please visit our contact page or connect with a member of The Richards Group team at (262) 326-4750.

Get a Quote Today!

Enjoy this blog? Please spread the word :)

Facebook
LinkedIn
Twitter
Instagram
YouTube
Pinterest
Follow by Email
Google+
http://richardsgroupinsurance.com/feed-items/sagent-pharmaceuticals-issues-voluntary-nationwide-recall-of-ketorolac-tromethamine-injection-usp-60mg-2ml-30mg-per-ml-due-to-lack-of-sterility-assurance">
RSS
Follow Us on LinkedIn Follow Us on Twitter Subscribe to Us on YouTube Follow Us on Facebook